MUSTANG BIO, INC. — Director's Dealing 2021

Aug 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2021-07-30

Reporting Person: Litchman Manuel MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-30	COMMON STOCK	P	86206	$2.91	Acquired	960241	Direct

Footnotes

F1: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on July 30, 2021, was $2.89 to $2.94. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price.

F2: Includes restricted stock units, which vest over various time periods.